ICOS and cancer: The inducible costimulator (ICOS) is a CD28-related molecule expressed on activated T cells and is capable of interacting with its ligand ICOSL, present on APCs such as like dendritic cells (DCs), B lymphocytes, and certain cancer cells (Huang et al., 2019).